成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Infigratinib: Synthesis and Introduction

Jan 29,2024

Synthesis of Infigratinib

Infigratinib was synthesized in a modular and convergent fashion via the union of three building blocks. The specific synthesis steps are as follows:

Step 1: Synthesis of Aniline-Containing Building Blocks (a) 32.4, (b) 32.6, and (c) 32.8

Piperidinesubstituted aniline 32.4 was prepared by the SNAr reaction of neat reagents piperidine 32.1 and bromonitrobenzene 32.2 at 80 °C followed by nitro reduction. 2,6-Dichloro-3,5- dimethoxyaniline (32.6) was accessed in 3 steps (acylation, chlorination, and hydrolysis) from commercially available 3,5- dimethoxyaniline (32.5), and 6-chloro-N-methylpyrimidin-4-amine (32.8) was prepared by the SNAr reaction of dichloropyrimidine 32.7 with methylamine.

Synthesis of Aniline-Containing Building Blocks (a) 32.4, (b) 32.6, and (c) 32.8

Step 2: Preparation of Infigratinib

Infigratinib was assembled by the SNAr reaction of aniline 32.4 with chloropyrimidine 32.8 to furnish aryl methyl amine 32.9. Aniline derivative 32.6 was converted to the corresponding isocyanate in situ and coupled with 32.9 to form the urea linkage and complete the synthesis of infigratinib.

Infigratinib Synthesis

Introduction of Infigratinib

Infigratinib is an orally bioavailable inhibitor against fibroblast growth factor receptor (FGFR)-specific tyrosine kinases. Co-developed by QED Therapeutics and Helsinn, infigratinib was approved by the USFDA in May 2021 for use in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements. Infigratinib displays highly selective, nanomolar inhibition of FGFR1, FGFR2, FGFR3, and FGFR4 in biochemical and cellular assays. Since activation of the FGFR pathway with underlying genetic abnormalities can cause proliferation of malignant cancer cells, inhibition of FGFR-specific kinases effectively reduces cell proliferation in tumors.

  • Related articles
  • Related Qustion
See also
4

Yes. The therapeutic fluoropyrimidines 5-fluorouracil (5-FU) and 5-fluorocytosine (5-FC) have long been used to treat human cancer and severe invasive fungal infections, respectively.....

Nov 1,2024Biochemical Engineering
4

Belzutifan was prepared by a synthetic route starting from 3,4-dihydrocoumarin, followed sequentially by the synthesis of Indanone Core and Indanone Ketal, and finally concentrating on three consecutive stereocentres present on the indane r....

Jan 29,2024Drugs

Infigratinib

872511-34-7

Infigratinib manufacturers

  • Infigratinib
  • 872511-34-7 Infigratinib
  • $39.00 / 5mg
  • 2024-11-18
  • CAS:872511-34-7
  • Min. Order:
  • Purity: 98.46%
  • Supply Ability: 10g
  • Infigratinib (BGJ398)
  • 872511-34-7 Infigratinib (BGJ398)
  • $0.00 / 1g
  • 2024-03-12
  • CAS:872511-34-7
  • Min. Order: 1g
  • Purity: 98% HPLC
  • Supply Ability: 1kg